Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Haffner

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Plos One|August 20, 2015
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic InflexibilityShian-Huey Chiang, W Wallace Harrington, Guizhen Luo, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Journal of Medicinal Chemistry|April 2, 2015
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 InhibitorsCurt D Haffner, J David Becherer, Eric E Boros, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsCurt D Haffner, Adam K Charnley, Christopher J Aquino, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Plos One|August 20, 2015
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic InflexibilityShian-Huey Chiang, W Wallace Harrington, Guizhen Luo, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Journal of Medicinal Chemistry|April 2, 2015
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 InhibitorsCurt D Haffner, J David Becherer, Eric E Boros, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase InhibitorsCurt D Haffner, Adam K Charnley, Christopher J Aquino, et al.
Pageof 9